Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Payables (2016 - 2025)

INVO Fertility (IVF) has disclosed Payables for 15 consecutive years, with $2.5 million as the latest value for Q3 2025.

  • On a quarterly basis, Payables fell 74.9% to $2.5 million in Q3 2025 year-over-year; TTM through Sep 2025 was $2.5 million, a 74.9% decrease, with the full-year FY2024 number at $8.3 million, up 62.67% from a year prior.
  • Payables was $2.5 million for Q3 2025 at INVO Fertility, down from $5.1 million in the prior quarter.
  • In the past five years, Payables ranged from a high of $11.3 million in Q1 2025 to a low of $306252.0 in Q2 2021.
  • A 5-year average of $3.7 million and a median of $2.9 million in 2023 define the central range for Payables.
  • Peak YoY movement for Payables: skyrocketed 574.25% in 2023, then tumbled 74.9% in 2025.
  • INVO Fertility's Payables stood at $896828.0 in 2021, then soared by 135.46% to $2.1 million in 2022, then soared by 141.24% to $5.1 million in 2023, then soared by 62.67% to $8.3 million in 2024, then tumbled by 69.34% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Payables are $2.5 million (Q3 2025), $5.1 million (Q2 2025), and $11.3 million (Q1 2025).